Immunohistochemistry (IHC) staining of these tumor samples showed a significant reduction of UBE2J1, accompanied by an increase in AR and AR target NKX3.1 proteins, in PCa compared to matched benign prostate tissue (Fig. 6J). Here, UBE2J1 is linked to posterior cortical atrophy.